Cargando…

Plasma rich in growth factors eye drops to treat secondary ocular surface disorders in patients with glaucoma

PURPOSE: To evaluate the efficacy and safety of plasma rich in growth factors (PRGF) eye drops in patients with glaucoma with secondary ocular surface disorders (OSDs) due to surgeries and topical hypotensive drugs use. MATERIALS AND METHODS: A retrospective case-series study design was used includi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sánchez-Avila, Ronald M, Merayo-Lloves, Jesus, Fernández, Maria Laura, Rodríguez-Gutiérrez, Luis Alberto, Rodríguez-Calvo, Pedro Pablo, Fernández-Vega Cueto, Andres, Muruzabal, Francisco, Orive, Gorka, Anitua, Eduardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937507/ https://www.ncbi.nlm.nih.gov/pubmed/29760570 http://dx.doi.org/10.2147/IMCRJ.S153918

Ejemplares similares

Plasma rich in growth factors membrane as coadjuvant treatment in the surgery of ocular surface disorders
por: Sanchez-Avila, Ronald M., et al.
Publicado: (2018)

Impact of Plasma Rich in Growth Factors (PRGF) Eye Drops on Ocular Redness and Symptomatology in Patients with Dry Eye Disease
por: Lozano-Sanroma, Javier, et al.
Publicado: (2023)

Differential Protein Content between Fresh and Freeze-Dried Plasma Rich in Growth Factors Eye Drops
por: Anitua, Eduardo, et al.
Publicado: (2022)

Development and Optimization of Freeze-Dried Eye Drops Derived From Plasma Rich in Growth Factors Technology
por: Anitua, Eduardo, et al.
Publicado: (2020)

Differential profile of protein expression on human keratocytes treated with autologous serum and plasma rich in growth factors (PRGF)
por: Anitua, Eduardo, et al.
Publicado: (2018)

Plasma Rich in Growth Factors as an Adjuvant Agent in Non-Penetrating Deep Sclerectomy
por: Rodríguez-Calvo, Pedro P., et al.
Publicado: (2023)

Optimization of a Plasma Rich in Growth Factors Membrane for the Treatment of Inflammatory Ocular Diseases
por: Anitua, Eduardo, et al.
Publicado: (2022)

Plasma Rich in Growth Factors for the Treatment of Cicatrizing Conjunctivitis
por: de la Sen-Corcuera, Borja, et al.
Publicado: (2020)

Plasma rich in growth factors versus Mitomycin C in photorefractive keratectomy
por: Sanchez-Avila, Ronald M., et al.
Publicado: (2021)

Use of Plasma Rich in Growth Factors and ReGeneraTing Agent Matrix for the Treatment of Corneal Diseases
por: Sánchez-Ávila, Ronald M., et al.
Publicado: (2021)

Proteomic Characterization of Plasma Rich in Growth Factors and Undiluted Autologous Serum
por: Anitua, Eduardo, et al.
Publicado: (2021)

Recovery of Corneal Innervation after Treatment in Dry Eye Disease: A Confocal Microscopy Study
por: Barros, Alberto, et al.
Publicado: (2023)

Fibrin-Plasma Rich in Growth Factors Membrane for the Treatment of a Rabbit Alkali-Burn Lesion
por: Sánchez-Ávila, Ronald M., et al.
Publicado: (2021)

Treatment of recurrent myopic macular hole using membrane of plasma rich in growth factors
por: Sánchez-Ávila, Ronald M, et al.
Publicado: (2019)

Plasma Rich in Growth Factors in Macular Hole Surgery
por: Sánchez-Ávila, Ronald M., et al.
Publicado: (2022)

PRGF Membrane with Tailored Optical Properties Preserves the Cytoprotective Effect of Plasma Rich in Growth Factors: In Vitro Model of Retinal Pigment Epithelial Cells
por: Anitua, Eduardo, et al.
Publicado: (2023)

Plasma Rich in Growth Factors Enhances Cell Survival after in Situ Retinal Degeneration
por: Suárez-Barrio, Carlota, et al.
Publicado: (2020)

Antioxidant Role of PRGF on RPE Cells after Blue Light Insult as a Therapy for Neurodegenerative Diseases
por: Suárez-Barrio, Carlota, et al.
Publicado: (2020)

Plasma rich in growth factors in dogs: Two sides of the same coin
por: Anitua, Eduardo, et al.
Publicado: (2017)

Membrane of Plasma Rich in Growth Factors in Primary Pterygium Surgery Compared to Amniotic Membrane Transplantation and Conjunctival Autograft
por: Idoipe, Miriam, et al.
Publicado: (2021)

Plasma Rich in Growth Factors Promotes Autophagy in ARPE19 Cells in Response to Oxidative Stress Induced by Blue Light
por: Suárez-Barrio, Carlota, et al.
Publicado: (2021)

Biological and Adhesive Properties of an Autologous Protein-Based Fibrin Sealant for Ophthalmological Applications
por: Anitua, Eduardo, et al.
Publicado: (2023)

The Ocular Status of Cystinosis Patients Receiving a Hospital Pharmacy-Made Preparation of Cysteamine Eye Drops: A Case Series
por: Biswas, Susmito, et al.
Publicado: (2018)

Autologous Platelet-Rich Plasma Eye Drops for the Treatment of Post-LASIK Chronic Ocular Surface Syndrome
por: Alio, Jorge L., et al.
Publicado: (2017)

Assessment by Optical Coherence Tomography of Short-Term Changes in IOP-Related Structures Caused by Wearing Scleral Lenses
por: Queiruga-Piñeiro, Juan, et al.
Publicado: (2023)

Small fiber neuropathy in the cornea of Covid-19 patients associated with the generation of ocular surface disease
por: Barros, Alberto, et al.
Publicado: (2022)

Leukocyte Inclusion within a Platelet Rich Plasma-Derived Fibrin Scaffold Stimulates a More Pro-Inflammatory Environment and Alters Fibrin Properties
por: Anitua, Eduardo, et al.
Publicado: (2015)

Platelet Rich Plasma and Knee Surgery
por: Sánchez, Mikel, et al.
Publicado: (2014)

Long-Term Follow-Up of Intrastromal Corneal Ring Segments in Paracentral Keratoconus with Coincident Corneal Keratometric, Comatic, and Refractive Axes: Stability of the Procedure
por: Fernández-Vega Cueto, Luis, et al.
Publicado: (2017)

Novel Diagnostic and Therapeutic Methods in Ocular Surface and Corneal Diseases
por: Nowinska, Anna K., et al.
Publicado: (2017)

What Causes Eye Pain?
por: Belmonte, Carlos, et al.
Publicado: (2015)

Exosomes Released by Corneal Stromal Cells Show Molecular Alterations in Keratoconus Patients and Induce Different Cellular Behavior
por: Lozano, Víctor, et al.
Publicado: (2022)

Systane(®) lubricant eye drops in the management of ocular dryness
por: Benelli, Umberto
Publicado: (2011)

Continuous 24-hour ocular dimensional profile recording in medically treated normal-tension glaucoma
por: Lee, Jacky WY, et al.
Publicado: (2015)

Efficacy of Garcinia kola 0.5% Aqueous Eye Drops in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
por: Adefule-Ositelu, Adebukunola O., et al.
Publicado: (2010)

Benzalkonium Chloride Resistance in Staphylococcus epidermidis on the Ocular Surface of Glaucoma Patients Under Long-Term Administration of Eye Drops
por: Lee, Jinhee, et al.
Publicado: (2020)

A pharmacoeconomic analysis to determine the relative cost-effectiveness of bimatoprost 0.03% eye drops and brimonidine 0.2% eye drops in patients of primary open-angle glaucoma/ocular hypertension
por: Natt, Navreet Kaur, et al.
Publicado: (2014)

An Autologous Topical Serum Derived from Platelet-Rich Plasma Therapy for the Management of Sensitive Skin Alterations: A Case Series Report
por: García-Millan, Cristina, et al.
Publicado: (2022)

Assessing the adherence behavior of glaucoma patients to topical eye drops
por: Welge-Lussen, Ulrich, et al.
Publicado: (2014)

An Ilomastat-CD Eye Drop Formulation to Treat Ocular Scarring
por: Mohamed-Ahmed, Abeer H. A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nigsvk7imi0u26lb9nvsobctgq